首页> 美国卫生研究院文献>other >Injection drug use and Hepatitis C as risk factors for mortality in HIV-infected individuals: the Antiretroviral Therapy Cohort Collaboration

【2h】

Injection drug use and Hepatitis C as risk factors for mortality in HIV-infected individuals: the Antiretroviral Therapy Cohort Collaboration

机译：注射毒品和丙型肝炎是艾滋病毒感染者死亡的危险因素：抗逆转录病毒疗法队列研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundHIV-infected individuals with a history of transmission via injection drug use (IDU) have poorer survival than other risk groups. The extent to which higher rates of hepatitis C (HCV) infection in IDU explain survival differences is unclear.

机译：背景艾滋病毒感染者具有通过注射吸毒传播的历史（IDU），其存活率较其他风险人群差。尚不清楚IDU中丙型肝炎（HCV）感染率的高低可解释生存差异。

著录项

期刊名称 other
作者
Margaret T May; Amy C Justice; Kate Birnie; Suzanne M Ingle; Colette Smit; Colette Smith; Didier Neau; Marguerite Guiguet; Carolynne Schwarze-Zander; Santiago Moreno; Jodie L. Guest; Antonella d’Arminio Monforte; Cristina Tural; Michael J Gill; Andrea Bregenzer; Ole Kirk; Michael Saag; Timothy R Sterling; Heidi M Crane; Jonathan A C Sterne;
展开▼
作者单位

展开▼
年(卷),期 -1(69),3
年度 -1
页码 348–354
总页数 15
原文格式 PDF
正文语种
中图分类
关键词
HIV-1 Hepatitis C virus injection drug use antiretroviral therapy cohort study mortality;

机译：HIV-1;丙型肝炎病毒;注射药物使用;抗逆转录病毒疗法;队列研究;死亡率;

相似文献

外文文献
中文文献
专利

1. Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration [J] . May Margaret T., Justice Amy C., Birnie Kate, JAIDS: Journal of acquired immune deficiency syndromes . 2015 ,第3期

机译：注射药物的使用和丙型肝炎是艾滋病毒感染者死亡率的危险因素：抗逆转录病毒疗法队列合作
2. Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users. [J] . Zitta Barrella Harboe, Mette Vang Larsen, Steen Ladelund, Clinical infectious diseases . 2014 ,第8期

机译：引入抗逆转录病毒治疗前后，艾滋病毒感染者和非艾滋病毒感染者中侵袭性肺炎球菌疾病的发病率和危险因素：艾滋病毒感染的注射吸毒者中持续存在高风险。
3. Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users. [J] . Zitta Barrella Harboe, Mette Vang Larsen, Steen Ladelund, Clinical infectious diseases . 2014 ,第8期

机译：引入抗逆转录病毒治疗前后，艾滋病毒感染者和非艾滋病毒感染者中侵袭性肺炎球菌疾病的发病率和危险因素：艾滋病毒感染的注射吸毒者中持续存在高风险。
4. Effect of highly active antiretroviral therapy (HAART) on lipid abnormalities in HIV-infected patients [C] . Estari Mamidala 2011 international conference on medical information and bioengineering. . 2011

机译：高效抗逆转录病毒疗法（HAART）对HIV感染患者血脂异常的影响
5. Trends in cancer and development of AIDS in HIV-infected individuals before and after implementation of highly active antiretroviral therapy. [D] . Martin, Rose Marie. 2010

机译：在实施高效抗逆转录病毒治疗前后，艾滋病毒感染者的癌症和艾滋病发展趋势。
6. Long-Term Outcomes and Risk Factors for Mortality in a Cohort of HIV-Infected Children Receiving Antiretroviral Therapy in Vietnam [O] . Rang Ngoc Nguyen, Quang Chanh Ton, My Huong Luong, 2020

机译：在越南接受抗逆转录病毒治疗的艾滋病毒感染儿童队列死亡率的长期结果和危险因素
7. Incidence and Risk Factors for Invasive Pneumococcal Disease in HIV-Infected and Non-HIV-Infected Individuals Before and After the Introduction of Combination Antiretroviral Therapy: Persistent High Risk Among HIV-Infected Injecting Drug Users [O] . Z. B. Harboe, M. V. Larsen, S. Ladelund, 2014

机译：在引入组合抗逆转录病毒治疗之前和之后的艾滋病毒感染和非艾滋病毒感染个体中侵袭性肺炎球菌病的发病率和危险因素：艾滋病毒感染的注射药物持续性高风险

Injection drug use and Hepatitis C as risk factors for mortality in HIV-infected individuals: the Antiretroviral Therapy Cohort Collaboration

摘要

著录项

相似文献

相关主题

期刊订阅